Michelle S Cespedes, MD
- ASSOCIATE PROFESSOR | Medicine, Infectious Diseases
Michelle S. Cespedes, MD, MS, joined the Division of Infectious Disease at the Icahn School of Medicine at Mount Sinai as an Associate Professor of Medicine in 2014. Her research areas of interest are complications and comorbidities of HIV, with an emphasis on HPV, HIV related women's health issues, and HIV prevention in high risk populations. Her basic science interest is genetic factors that predispose HIV infected patients to HPV disease. She is currently the protocol vice-chair of two AIDS Clinical Trial Group (ACTG) studies designed to evaluate the HPV vaccine in HIV infected populations. In 2014, she was named the co-Director of ID Division’s Clinical and Translational Research Center at Mount Sinai and the clinical research site leader of Mt. Sinai West's Samuels Clinic. Nationally, she sits on the ACTG Executive Committee and is the Chair of its Underrepresented Populations Committee.
Please read her article on syphillis in Our Town.
MD, Mount Sinai School of Medicine
MS, New York University School of Medicine
Residency, Internal Medicine, Memorial Sloan-Kettering Cancer Center
Residency, Internal Medicine, New York Presbyterian - Weill Cornell Medical Center
Fellowship, Infectious Disease, Bellevue Hospital Center
- A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex with Men and Are at Risk of HIV-1 Infection
In 2014 there were more than 2 million new HIV infections estimated world-wide even though there is widespread knowledge of how to prevent acquiring the HIV infection. In July 2012, the FDA approved to expand the use of emtricitabine/ tenofovir disopoxil fumarate (F/TDF) in co...
Cespedes MS, Kerns SL, Holzman RS, McLaren PJ, Ostrer H, Aberg JA. Genetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268. HIV clinical trials 2013; 14(6).
Kojic EM, Kang M, Cespedes MS, Umbleja T, Godfrey C, Allen RT, Firnhaber C, Grinsztejn B, Palefsky JM, Webster-Cyriaque JY, Saah A, Aberg JA, Cu-Uvin S. Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014 Jul; 59(1).
Cespedes MS, Castor D, Ford SL, Lee D, Lou Y, Pakes GE, Aberg JA. Steady-state pharmacokinetics, cord blood concentrations, and safety of ritonavir-boosted fosamprenavir in pregnancy. Journal of acquired immune deficiency syndromes (1999) 2013 Apr; 62(5).
Coleman JS, Cespedes MS, Cu-Uvin S, Kosgei RJ, Maloba M, Anderson J, Wilkin T, Jaquet A, Bohlius J, Anastos K, Wools-Kaloustian K. An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan Africa. Journal of lower genital tract disease 2016 Jan; 20(1).
Castillo-Mancilla JR, Cohn SE, Krishnan S, Cespedes M, Floris-Moore M, Schulte G, Pavlov G, Mildvan D, Smith KY, Actg Underrepresented Populations Survey Group . Minorities remain underrepresented in HIV/AIDS research despite access to clinical trials. HIV clinical trials; 15(1).
Heumann C, Cohn SE, Krishnan S, Castillo-Mancilla JR, Cespedes M, Floris-Moore M, Smith KY. Regional variation in HIV clinical trials participation in the United States. Southern medical journal 2015 Feb; 108(2).
Zhang X, Hunt PW, Hammer SM, Cespedes MS, Patterson KB, Bosch RJ. Immune Activation While on Potent Antiretroviral Therapy Can Predict Subsequent CD4+ T-Cell Increases Through 15 Years of Treatment. HIV clinical trials 2013; 14(2).
Taliercio S, Cespedes M, Born H, Ruiz R, Roof S, Amin MR, Branski RC. Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling. JAMA otolaryngology-- head & neck surgery 2015 Jan; 141(1).
Cespedes MS, Aberg JA. Cardiovascular and Endothelial Disease in HIV Infection. Current infectious disease reports 2005 Jul; 7(4).
Cespedes MS, Aberg JA. Neuropsychiatric complications of antiretroviral therapy. Drug safety 2006; 29(10).
Johnson MA, Smith H, Joeph P, Gilman RH, Bautista CT, Campos KJ, Cespedes M, Klatsky P, Vidal C, Terry H, Calderon MM, Coral C, Cabrera L, Parmar PS, Vinetz JM. Environmental exposure and leptospirosis, Peru. Emerging infectious diseases 2004 Jun; 10(6).